Molecular insight into lymphoma
Complex lymphoproliferative diseases are characterised by the abnormal proliferation of lymphocytes and exhibit clinical aggressiveness as well as low therapeutic response. Information on disease pathogenesis and targeted therapies is scarce due to limited data on predictor markers and poor experimental models. The EU-funded PRECISMEDLYM project focuses on T cell lymphoma that presents a polyclonal profile and exhibits dismal prognosis and frequent relapse. Scientists will investigate the molecular basis of different lymphoma subtypes and identify therapeutic targets through gene expression analysis. This information will be central for patient stratification, supporting precision medicine efforts with reduced toxicity and improved efficacy.
Call for proposal
See other projects for this call